Eurand Eurand Eurand Eurand Eurand Eurand Eurand
Zenpep

Eurand is developing and commercializing our own portfolio of therapeutic products in the U.S. to address conditions associated with cystic fibrosis and gastrointestinal disorders.

Runners

Eurand (NASDAQ: EURX) is a global specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies.

Licensing

Product Licensing Opportunities
Eurand has a portfolio of existing products available in a variety of therapeutic categories.

News

+ view all

Stock Information

Development Pipeline

Eurand has a range of products in various stages of development.

Click Now

Customized Drug Release

Pharmaceutical technologies for formulation development and life cycle management solutions.

Click Now

Products for Out-Licensing

Learn more about Eurand’s portfolio of products available for out-licensing

Click Now

AMRIX® is a registered trademark of Cephalon, Inc., or its affiliates
Zenpep® is a registered trademark of Eurand Pharmaceuticals, Ltd.